[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Forestier et al., 1985 - Google Patents

Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy

Forestier et al., 1985

Document ID
16921196980053520226
Author
Forestier F
Daffos F
Rainaut M
Sole Y
Amiral J
Publication year
Publication venue
Thrombosis and haemostasis

External Links

Snippet

The vitamin K dependent coagulation factor activities were measured in 63 normal human fetuses from 19 to 28 weeks of pregnancy. These activities were included between 9 to 28 percent of normal adult levels. Prothrombin antigen, factor IX antigen and protein C were …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Similar Documents

Publication Publication Date Title
Forestier et al. Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy
US5525478A (en) Soluble thrombomodulin-based one-stage assay for vitamin-K dependent coagulation-inhibiting proteins
d'Angelo et al. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.
Soria et al. A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis
JP4486999B2 (en) Kit for determining coagulation parameters
US5051357A (en) Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
CA2623142C (en) Methods for a global assay of coagulation and fibrinolysis
JPH10508945A (en) Diagnosis of thrombotic diseases
WO2002079375A1 (en) Rapid assessment of coagulation activity in whole blood
Briët et al. Molecular variant of factor VII
Nizzi et al. Protein C and S deficiency
Fukuda et al. Measuring tissue factor (factor III) activity in plasma.
Ratnoff Hemostatic mechanisms in liver disease
Moalic et al. Levels and plasma distribution of free and C4b-BP-bound protein S in human fetuses and full-term newborns
España et al. Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays
Suarez et al. Neonatal and maternal fibrinolysis: activation at time of birth
Van Wijk et al. Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.
Kaplan et al. Molecular mechanisms of fibrinolysis in man
Kondo et al. Cold Activation of Complement: I. Presence of Coagulation-Related Activator
Melissari et al. Protein S and C4b‐binding protein in fetal and neonatal blood
Forestier et al. Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance
Guglielmone et al. A Novel Functional Assay of Protein C in Human Plasma and fts Comparison with Amidolytic and Anticoagulant Assays
CA2039173C (en) Factor ix chromogenic assay
Jacobsen Proteolytic Capacity in Human Plasma Part I Measurement of proteolytic activity in the presence of natural inhibitors and study of the inter-individual variations
van Dieijenc Use of Chromogenic Peptide Substrates in the Determination of Clotting Factors IIo VII, IX and X in Normal Plasma and in Plasma of Patients Treated with Oral Anticoagulants